Clinical trial Recruiting at 23 sites Phase 4 Interventional Ages 40 to 60 Women only

Hormone therapy for hot flashes in women living with HIV

Official title: Menopausal Hormone Therapy for Women Living With HIV (HoT)

Run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · NCT06856174 · Data updated 2026-11-12

This study tests whether transdermal estradiol (with or without progesterone) can relieve hot flashes and improve quality of life for women living with HIV who are going through menopause.

More HIV Infection trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages40 Years to 60 Years
SexWomen only
Enrollment105 (estimated)
SponsorAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Research network
Locations23 sites (Birmingham, Alabama and 22 other locations)
StatusRecruiting
StartedApril 9, 2026
Main results expectedSeptember 20, 2027
Study endsSeptember 20, 2027
Registry record updatedMay 22, 2026
Trial IDNCT06856174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 40–60 living with HIV, in late perimenopause or early postmenopause, who experience hot flashes or night sweats and meet safety criteria for hormone therapy.

Probably not a fit

Some participants may not experience symptom relief or may encounter side effects or contraindications that limit benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 4 trial will evaluate the safety and effectiveness of transdermal estradiol gel with or without micronized progesterone compared with placebos in women living with HIV who are late perimenopausal or early postmenopausal and experience hot flashes or night sweats. Participants will use daily diaries to track symptoms and daily functioning, sleep, mood, and bone health measures. The study aims to determine if hormone therapy offers benefits beyond symptom relief, including improvements in mood, sleep, mental function, and bone health, without unacceptable risks. The trial is conducted at multiple centers in the United States and is sponsored with collaborators from NIAID, NIA, and Exeltis.

Why it matters

Potential benefit: If successful, participants may experience relief from hot flashes and night sweats and potential improvements in sleep, mood, and bone health.

How similar studies have gone: Prior hormone therapy trials show symptom relief in the general population, but data in women living with HIV are limited and this study adds specific evidence for this group.

Who can join: the full rules

Show full inclusion / exclusion criteria
* Living with HIV
* Assigned female sex at birth
* Between the ages of 40 and 60 years
* In the late menopausal transition (perimenopause) or early postmenopause
* Experiencing hot flashes and/or night sweats
* Willing and able to complete a daily diary
* Does not have medical condition that would contraindicate hormone therapy
* Not taking medications to treat hot flashes
* Not taking medications that cannot be combined with hormone therapy
* Receiving antiretrovirals (HIV medication) for more than 1 year
* Not pregnant and willing and able to use at least non-hormonal birth control to prevent pregnancy
* Willing and able to provide informed consent after discussion with the research staff

Where it's running

  • 31788 Alabama CRS
    Birmingham, Alabama, United States
    Recruiting
  • University of California, Los Angeles CARE Center CRS (601)
    Los Angeles, California, United States
    Recruiting
  • UCSD Antiviral Research Center CRS (701)
    San Diego, California, United States
    Recruiting
  • 801 University of California, San Francisco HIV/AIDS CRS
    San Francisco, California, United States
    Recruiting
  • Harbor - UCLA Med. Ctr. CRS
    Torrance, California, United States
    Recruiting
  • University of Colorado Hospital CRS (6101)
    Aurora, Colorado, United States
    Recruiting
Show 17 more locations
  • The Ponce de Leon Center CRS (5802)
    Atlanta, Georgia, United States
    Recruiting
  • Northwestern University CRS (2701)
    Chicago, Illinois, United States
    Recruiting
  • 201 Johns Hopkins University CRS
    Baltimore, Maryland, United States
    Recruiting
  • 101 Massachusetts General Hospital (MGH) CRS
    Boston, Massachusetts, United States
    Recruiting
  • Brigham and Women's Hosp. ACTG CRS (107)
    Boston, Massachusetts, United States
    Recruiting
  • 2101 Washington University Therapeutics (WT) CRS
    St Louis, Missouri, United States
    Recruiting
  • New Jersey Medical School Clinical Research Center CRS (31786)
    Newark, New Jersey, United States
    Recruiting
  • Weill Cornell Chelsea CRS (7804)
    New York, New York, United States
    Recruiting
  • Columbia Physicians and Surgeons (P&S) CRS (30329)
    New York, New York, United States
    Recruiting
  • 3201 Chapel Hill CRS
    Chapel Hill, North Carolina, United States
    Recruiting
  • 3203 Greensboro CRS
    Greensboro, North Carolina, United States
    Recruiting
  • 2401 Cincinnati CRS
    Cincinnati, Ohio, United States
    Recruiting
  • Case CRS (2501)
    Cleveland, Ohio, United States
    Recruiting
  • Ohio State University CRS (2301)
    Columbus, Ohio, United States
    Recruiting
  • 6201 Penn Therapeutics CRS
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Univ of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Houston AIDS Research Team CRS (31473)
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.